Qian Xu, Lingling Du, Heng Gu, Meng Ji, Ling Zhan
Número de descargas:
8971
Número de visitas:
3967
Citas:
0
Compártelo:
Background: in recent years, n-3 PUFAs have been confirmed to be associated with cardiovascular and cerebrovascular diseases, but the link between n-3 PUFAs and stroke remains controversial. Objective: this study aimed to evaluate the association between n-3 PUFAs and stroke. Methods: we performed a comprehensive search of the following electronic databases: PubMed, Embase, Cochrane Library, Web of Science and CNKI. Literature screening and quality assessment were performed according to inclusion and exclusion criteria. Cochrane’s tool was used to assess the methodological components of each study, and the Stata 15.1 software was used to perform the meta-analysis. Results: a total of 18 RCTs were included, and the meta-analysis showed no differences in vascular disease-related death between the n-3 PUFA and control groups (RR, 0.95, 95 % CI: 0.89 to 1.01, p = 0.114 > 0.05). However, there was a significant difference in the lower n-3 PUFA dose subgroup (RR, 0.93, 95 % CI: 0.87 to 0.99, p = 0.034 < 0.05). Oral administration of n-3 PUFAs did not significantly reduce the risk of the following cerebrovascular accidents: stroke (RR = 1.00, 95 % CI: 0.93 to 1.07, p = 0.983 > 0.05), ischemic stroke (RR = 0.99, 95 % CI: 0.896 to 1.094, p = 0.841 > 0.05), hemorrhagic stroke (RR = 1.249, 95 % CI: 0.939 to 1.662, p = 0.127 > 0.05) and TIA (RR = 1.016, 95 % CI: 0.882 to 1.170, p = 0.824 > 0.05). The levels of TC (SMD, -0.167, 95 % CI: −0.193 to -0.141, p = 0 < 0.05) and TG (SMD, -0.065, 95 % CI: -0.087 to -0.042, p = 0 < 0.05) in the n-3 PUFA group were significantly decreased, but no significant improvement in the LDL (SMD, 0.022, 95 % CI: 0.005 to 0.040, p = 0.889 > 0.05) and HDL (SMD, 0.008, 95 % CI: -0.009 to 0.025, p = 0.368 > 0.05) levels was observed. Conclusion: this systematic review and meta-analysis suggests that treatment with low-dose n-3 PUFAs can reduce cerebrovascular disease-related death. After the oral administration of n-3 PUFAs, the levels of TC and TG decreased significantly, but n-3 PUFAs did not prevent the occurrence of cerebrovascular accidents or improve LDL or HDL levels.
Palabras Clave: n-3 PUFAs; stroke; meta-analysis
Ismael San Mauro-martin , Ana María Ruiz-león , María Alicia Camina-martín , Elena Garicano-vilar , Luis Collado-yurrita , Beatriz De Mateo-silleras , María De Paz Redondo Del Río
Raúl Aguilera-Eguía , Paula Jessica Jorquera Pino , Claudia Jaqueline Salgado , Cherie Flores
Raúl Aguilera-Eguía , Paule Jessica Jorquera Pino , Claudia Jaqueline Salgado , Cherie Flores
Raúl Aguilera-Eguía , Patricio Arroyo Jofr
Carlos Cristi-Montero , Patricio Solís-urra , Fernando Rodríguez-Rodríguez
Raúl Aguilera-Eguía
Raúl Aguilera-Eguía , Paula Jessica Jorquera Pino , Claudia Jaqueline Salgado , Cherie Flores
Fidel López Espuela , Juan Carlos Portilla Cuenca , Marta Holguín Mohedas , José Manuel Párraga Sánchez , Sergio Cordovilla-guardia , Ignacio Casado Naranjo
María Dolores Ballesteros Pomar , Laura Palazuelo Amez
Yuanfeng Gong , Fengying Dong , Yan Geng , Hongkai Zhuang , Zuyi Ma , Zixuan Zhou , Bowen Huang , Zhonghai Sun , Baohua Hou
Alejandra Mora Mendoza , Francisca Pereyra-García Castro , José Gregorio Oliva García , José Pablo Suárez Llanos , Antonio Medina Rodriguez , Nieves Caracena Castellanos , María Aracelí García Nuñez , José Enrique Palacio Abizanda
Rodrigo Fernandes Weyll Pimentel , Sandra Lúcia Fernandes
Raúl Aguilera-Eguía , Héctor Fuentes-Barría , Olga López-Soto
Erika Sáenz-Pardo-Reyes , Fátima Ezzahra Housni , Antonio López Espinoza , Alma Gabriela Martínez Moreno , Maria del Rocio Padilla Galindo , Gabriela Velázquez Saucedo
Raúl Aguilera-Eguía , Héctor Fuentes Barría , Olga Patricia López-Soto
Kaiwen Sun , Zhenzhu Liu , Hongyan Wang
Meijuan Li , Jingyun Yuan
Xiang-Tian Meng , Yun-Yue Shi , Zhou Hong-Yan
YanPing Liu , Dejian Ma , XiYan Wang , YunZhi Fang
Yang Bin , Liao Kang , Yuan Lili
Patricia Murciego , Paula Giménez Barriga , Natividad García Atarés
Raúl Aguilera-Eguía , Héctor Fuentes-Barría , Cristian Yáñez-Baeza , Víctor Pérez-Galdavini , Gloria Inostroza-Reyes , Ángel Roco-Videla
Raúl Aguilera-Eguía , Héctor Fuentes-Barría , Cristian Yáñez-Baeza , Víctor Pérez-Galdavini , Gloria Inostroza-Reyes , Ángel Roco-Videla
Yun Zhou , Tian-Tian Li , Zhi-liang Yang , Zhi-Ming Tan , Chi-Fen Yang , Zheng Wang
Qiwei Xie , Jiatian Yuan , Yaoweng Wang
Raúl Aguilera-Eguía , Gloria Inostroza-Reyes , Héctor Fuentes-Barría , Ángel Roco-Videla
Raúl Aguilera-Eguía , Gloria Inostroza-Reyes , Héctor Fuentes-Barría , Ángel Roco-Videla
José Miguel Sánchez-Nieto , Denisse Itzel Sierra-Zurita , Mirna Ruiz-Ramos , Víctor Manuel Mendoza-Núñez
Siyu Liu , Junhui Chen , Yiwen Wang , Yangyang Xu
Xi Zhao , Jie Wang , Long Zou
Raúl Aguilera-Eguía , Cristian Yáñez-Baeza , Héctor Fuentes-Barría , Ángel Roco-Videla
María González-Herrera , Mónica García-García , Cristina Diez-Arroyo , Ángela Hernández-Ruiz
Hao-Ning Lan , Xu-Ying Huang , Yang Ge , Guang-Yu An , Jian-Nan Yao , Hui-Yun Zhang
Chiqiong Liu , Gyung Park
Raúl Aguilera-Eguía , Ángel Roco Videla , Héctor Fuentes-Barría , Víctor Pérez-Galdavini
Qianran Kong , Lijuan Tian , Yihan Wang , Min Yu
Jiaxin You , Jinjie Hou , Xiaoran Xie , Rong Xu
Xiaoyi Huang , Guihao Huang , Guiju Wei
Ante cualquier agresión, el organismo pone en marc...
El paciente crítico presenta una respuesta metaból...